Zaleplon 57237-0239
Product NDC
57237-0239- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- June 6, 2008
- Listing Expires
- December 31, 2026
- Application
- ANDA078829
Active Ingredients
| Ingredient | Strength |
|---|---|
| Zaleplon | 5 mg/1 |
Drug Class
gamma-Aminobutyric Acid A Receptor Agonist [EPC]Central Nervous System Depression [PE]GABA A Agonists [MoA]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (57237-239-01)